Enantioselective Chromatographic Analysis of Formoterol Fumarate using Chiral Mobile Phase Additives and Achiral Core-Shell Column [PDF]
, 2020 A simple, robust, cost-effective, and rapid RP-HPLC method was developed for the separation of enantiomers of formoterol. The separation was achieved by the chiral mobile phase additive technique on an achiral column.
Pranav, Pathak, Krishnapriya, Mohanraj
core +1 more source
Respiratory Research, 2021 Background In the Phase III KRONOS study, triple therapy with budesonide/glycopyrronium/formoterol fumarate metered dose inhaler (BGF MDI) was shown to reduce exacerbations and improve lung function versus glycopyrronium/formoterol fumarate dihydrate ...
Shigeo Muro +3 more
doaj +1 more source
Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]
, 2012 Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates +3 more
core +1 more source
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events [PDF]
, 2010 Background An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in comparison with placebo in previous Cochrane reviews.
Christopher J Cates +3 more
core +1 more source
Combination formoterol and inhaled steroid versus beta(2)-agonist as relief medication for chronic asthma in adults and children (Review) [PDF]
, 2009 Background Formoterol has a fast onset of action and can therefore be used to relieve symptoms of asthma. A combination inhaler can deliver formoterol with different doses of inhaled corticosteroid; when used as a reliever both drugs will be delivered ...
Lasserson, TJ, Cates, CJ
core +1 more source
Jornal Brasileiro de Pneumologia, 2012 OBJETIVO: Avaliar a equivalência farmacêutica da formulação teste (associação fixa de budesonida e fumarato de formoterol em cápsula única dispensada com o dispositivo Aerocaps®) em relação a uma formulação referência (budesonida e fumarato de formoterol
Marina Andrade-Lima +2 more
doaj +1 more source
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events [PDF]
, 2012 An increase in serious adverse events with both regular formoterol and regular salmeterol in chronic asthma has been demonstrated in previous Cochrane reviews.ObjectivesWe set out to compare the risks of mortality and non-fatal serious adverse events in ...
Christopher J Cates +3 more
core +1 more source
Therapeutic Advances in Respiratory Disease, 2021 Background: In the phase III, 52-week ETHOS study in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), triple therapy with budesonide/glycopyrrolate/formoterol fumarate (BGF), at two inhaled corticosteroid dose levels ...
Klaus F. Rabe +7 more
doaj +1 more source
Long-term safety of nebulized formoterol: Results of a twelve-month open-label clinical trial
Therapeutic Advances in Respiratory Disease, 2008 Formoterol fumarate is a long-acting β 2-agonist that is an effective bronchodilator for the maintenance management of patients with chronic obstructive pulmonary disease.
James F. Donohue +5 more
doaj +1 more source
Kajian Pustaka Efektivitas dan Efek Samping Terapi Kombinasi Budesonide - Formoterol Fumarate pada Pasien Asma [PDF]
, 2023 Asma merupakan suatu penyakit yang ditandai dengan adanya inflamasi kronis pada saluran pernapasan, ditandai dengan adanya gejala seperti mengi, sesak napas, sesak pada bagian dada, batuk yang terjadi secara berulang karena adanya penyumbatan dan ...
Oqviani, Riri Nur +5 more
core +1 more source